Development and in vitro evaluation of a copper-64 radiolabeled antibody for targeting the CXCR4 receptor in human multiple myeloma - Université de Bretagne Occidentale
Journal Articles Nuclear Medicine and Biology Year : 2022

Development and in vitro evaluation of a copper-64 radiolabeled antibody for targeting the CXCR4 receptor in human multiple myeloma

Cassandra Métivier
  • Function : Author
Patricia Le Saec
Hela Bouhsine
  • Function : Author
Séverine Marionneau-Lambot
Emmanuel Garçion
  • Function : Author
Raphaël Tripier
Chimie, Electrochimie Moléculaires et Chimie Analytique
Ferid Haddad
  • Function : Author
Michel Chérel
Alain Faivre-Chauvet
Latifa Rbah-Vidal
  • Function : Author

Domains

Chemical Sciences

Raphaël Tripier  : Connect in order to contact the contributor

https://hal.univ-brest.fr/hal-04545853

Submitted on : Sunday, April 14, 2024-8:09:17 PM

Last modification on : Tuesday, September 24, 2024-4:19:25 PM

No file

Dates and versions

hal-04545853 , version 1 (14-04-2024)

Identifiers

Cite

Cassandra Métivier, Patricia Le Saec, Hela Bouhsine, Séverine Marionneau-Lambot, Emmanuel Garçion, et al.. Development and in vitro evaluation of a copper-64 radiolabeled antibody for targeting the CXCR4 receptor in human multiple myeloma. Nuclear Medicine and Biology, 2022, 108-109, pp.S203-S204. ⟨10.1016/S0969-8051(22)00419-X⟩. ⟨hal-04545853⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

UNIV-BREST CNRS INC-CNRS CEMCA-BREST IBSAM
9 View
0 Download

Altmetric

Share

More